Yes, I've been wondering if Columbia may take a stake in RNO as well.
The announcement from 21/6/18 mentions "other commercial issues".
"The binding agreement (which the parties hope to complete in the next 90 days) will deal with the licensing of Rhinomed’s platform technology, intellectual property, product royalties and supply of technology, exclusivity and other commercial issues. The program will leverage Rhinomed’s nasal platform with development taking place in Columbia Care’s research and manufacturing facilities nationally".
Anyway, not long to wait now. We could be in a Trading Halt by this time next week.
RNO Price at posting:
25.5¢ Sentiment: Hold Disclosure: Held
